Archived Seminar: Unlocking the Neurodevelopmental Effects of Cannabis and Relevance to Psychiatric Risk
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
The sociopolitical landscape has dramatically changed regarding the medical and recreational use of cannabis. This talk will provide insights about advances made about the molecular underpinnings of developmental cannabis/THC exposure that maintains a long-term impact on adult behavior. The research describes translational and multidisciplinary scientific approaches ranging from molecular and epigenetic studies in animal models to investigations in human subjects.
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Human Neuroscience Research. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
General ItemVirtual Seminar: Reprogramming the Brain Cancer Stem Cell
March 5, 2021, 11 a.m. | John Laterra, M.D., Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Seminar: Effect of Contemporary Societal Exposures on Adolescent Behavioral Health
March 12, 2021, 11 a.m. | Adam Matthew Leventhal, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Public Lecture: Genes Regulating Sleep and Circadian Rhythms
March 25, 2021, 5:30 p.m. | Michael Young, Ph.D. | Maury Strauss Distinguished Public Lecture **Awarded the 2017 Nobel Prize in Physiology or Medicine**
General ItemVirtual Seminar: The Epigenetic Basis of Memory Formation and Dysregulation in Memory Disorders
April 2, 2021, 11 a.m. | Farah Lubin, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Lecture: Title to be announced
April 2, 2021, 1 p.m. | Alain Dagher, M.D. | Timothy A. Johnson Medical Scholar Seminar Series
Yasmin Hurd, Ph.D.
Professor in the Department of Psychiatry, Neuroscience, and Pharmacology, and the Department of Systems Therapeutics, at the Icahn School of Medicine; and Director of the Addiction Institute at Mount Sinai